CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Low-Level Laser Therapy (Photobiomodulation) — Coverage Criteria

This policy governs coverage and medical necessity determinations for low-level laser therapy (photobiomodulation) across Medicare Advantage and commercial products, specifying covered indication(s) and noncovered indications.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyLow-Level Laser Therapy (Photobiomodulation) — Coverage Criteria

Policy CodePolicy N/A

Change TypeAdministrative update

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionVerify member eligibility and benefits before providing LLLT and submit the applicable procedure code with relevant ICD-10 diagnosis codes when covered.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1Covered indication

11+Noncovered indications listed

3Procedure codes listed

600-1000Wavelength range (nm)

Coverage and Medical Necessity

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage — Prevention of oral mucositis

Covered when ALL of the following are met:

Prevention of oral mucositis: Patient is undergoing cancer treatment associated with increased risk of oral mucositis (including chemotherapy and/or radiotherapy and/or hematopoietic stem cell transplantation)

LLLT is covered for prevention of oral mucositis in these patients according to both Medicare Advantage and Commercial Products sections.

Coverage — Other indications not covered

Not covered / not medically necessary for all other indications:

Noncovered indications: Low-level laser therapy (LLLT)/photobiomodulation is not covered or is considered not medically necessary for indications other than prevention of oral mucositis due to insufficient evidence to determine effects on health outcomes

Examples listed include: carpal tunnel syndrome; neck pain; subacromial impingement; adhesive capsulitis; temporomandibular joint pain; low back pain; osteoarthritic knee pain; heel pain (Achilles tendinopathy, plantar fasciitis); rheumatoid arthritis; Bell's palsy; fibromyalgia; wound healing; lymphedema.

Low-level laser therapy (LLLT)/photobiomodulation is covered for prevention of oral mucositis when provided to patients undergoing cancer treatment associated with increased risk of oral mucositis (for example, chemotherapy, radiotherapy, and/or hematopoietic stem cell transplantation). This coverage applies per the Medicare Advantage and Commercial Products sections of the policy when the listed clinical criteria are met.

For all other indications, LLLT is not considered medically necessary or not covered because the evidence is insufficient to demonstrate meaningful improvement in health outcomes; examples of noncovered indications are provided in the policy.

Benefit coverage and payment for LLLT may vary by group or contract. Providers and payers should follow the member's applicable Benefit Booklet, Evidence of Coverage, subscriber agreement, or employer agreement to determine whether LLLT is a covered benefit for a specific member.

When a service is determined to be not medically necessary or to be a non-covered benefit under the member's contract, those determinations govern payment and billing (see provider notification and member financial liability notes).

For Commercial Products, LLLT is covered only for prevention of oral mucositis in patients at increased risk; for all other clinical indications the technology is considered not medically necessary due to insufficient evidence of benefit. Examples of indications with insufficient evidence include musculoskeletal, neurologic, lymphedema, and wound-healing applications listed in the policy.

Procedure and Diagnosis Codes

Covered procedure codesCPT | HCPCSCovered

0552T	Low-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professional
97037	Application of a modality to 1 or more areas; low-level laser therapy (ie, nonthermal and non ablative) for post-operative pain reduction
S8948	Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes

Related ICD-10 diagnosis codesICD-10

C00-D49	Neoplasms (used in document as ICD-10 range accompanying covered codes)
K12.30-K12.39	Disorders of the oral mucosa (oral mucositis) ICD-10 range

Provider Responsibilities and Billing Guidance

Documentation Required

Check Member Coverage Before Treatment

Check member coverage and eligibility before providing services. Benefits and coverage (including whether a service is a covered benefit or a non-covered benefit) vary by contract and subscriber agreement. Verify the member's subscriber agreement, Evidence of Coverage, or Benefit Booklet and confirm eligibility with the provider call center prior to treatment. Do not rely solely on this medical policy for benefit determinations.

Verify benefits and eligibility via the provider call center
Confirm subscriber/employer agreement and Evidence of Coverage for member-specific coverage
Obtain written member agreement if providing non-covered services and charging the member (per participation agreement)

Documentation Required

Coverage and Coding Documentation

When submitting claims for covered services, include the applicable procedure (CPT/HCPCS) and supporting ICD-10 diagnosis codes as indicated in the policy. Submit documentation that supports the medical necessity of the service when appropriate. Coverage may be limited to specific indications (see Coverage); services provided for indications listed as not covered or not medically necessary may be denied.

Covered codes include: 0552T, 97037, S8948 (file with relevant ICD-10 C00-D49 or K12.30-K12.39 as applicable)
Include supporting clinical documentation to justify medical necessity when requested

Note

This Section Lists Supporting Literature

This policy cites peer-reviewed studies and systematic reviews that support coverage decisions and delineate non-covered indications. Refer to the References section of the policy for the full list of supporting literature.

Denial Risk

Member Financial Liability and Denial Risk

Non-covered or not medically necessary services may be denied and are not payable by the plan. If a service is determined to be not medically necessary or a non-covered benefit, providers may not bill the member unless the member has been informed in writing and has agreed in advance to accept financial responsibility. Follow your participation/subscriber agreement for billing and collection requirements.

Examples of indications commonly considered not covered: carpal tunnel syndrome, neck pain, subacromial impingement, adhesive capsulitis, temporomandibular joint pain, low back pain, osteoarthritic knee pain, heel pain, rheumatoid arthritis, Bell palsy, fibromyalgia, wound healing, lymphedema

Clinical Background and Rationale

Low-level laser therapy (photobiomodulation) uses low-power red or near-infrared light intended to penetrate tissues without producing a thermal burn. Devices typically operate in the 600–1000 nm wavelength range and at low power levels; the precise mechanism is uncertain but is hypothesized to stimulate cellular repair processes and modulate inflammatory, immune, lymphatic, and vascular responses. LLLT has been investigated for oral mucositis prevention and a range of musculoskeletal, neurologic, lymphedema, and wound-healing conditions, though evidence sufficiency varies by indication.

Definitions and Terminology

LLLT / photobiomodulation definition (wavelengths, power range)

Wavelength range600–1000 nm (red-beam or near-infrared lasers)

Power range5–500 MW (low power; produces no sensation or skin burning)

Tissue effect hypothesisLow absorption by skin allows deeper penetration with a photobiostimulative effect

Oral mucositis — definition and clinical context

DefinitionInflammation of the oral mucosa typically manifesting as erythema or ulcerations

TimingOften appears 7–10 days after initiation of high‑dose cancer therapy

Clinical consequencesCan cause significant pain, increased systemic infection risk, need for total parenteral nutrition, and use of opioid analgesics

Photobiomodulation / Low-Level Laser Therapy (LLLT) — therapeutic intent

Therapeutic intentUse of low‑intensity lasers or LEDs intended to reduce pain, decrease inflammation, or promote tissue healing and repair

Applications evaluatedStudied for oral mucositis, musculoskeletal pain, tendinopathies, nerve injuries, joint pain, wound healing, and lymphedema

MechanismExact mechanism unknown; hypothesized stimulation of cellular repair and immune, lymphatic, and vascular systems

LLLT / Photobiomodulation — additional definition variant referenced

Alternate phrasingTherapeutic use of low‑power lasers or light‑emitting devices applied to tissue to attempt pain relief, reduce inflammation, or facilitate tissue healing

Evidence contextEvaluated across multiple randomized and controlled trials and systematic reviews for varied indications

Device variabilityIncludes both lasers and LEDs with differing wavelengths and power parameters described in referenced studies